Detalhe da pesquisa
1.
A confirmatory basket design considering non-inferiority and superiority testing.
J Biopharm Stat
; 34(2): 205-221, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988397
2.
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.
Br J Clin Pharmacol
; 71(3): 429-36, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21284702
3.
Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis.
Adv Ther
; 36(6): 1252-1265, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963514
4.
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
J Clin Endocrinol Metab
; 91(11): 4612-9, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16912128
5.
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Clin Ther
; 28(1): 55-72, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16490580
6.
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.
Clin Pharmacol Ther
; 78(6): 675-88, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16338283
7.
An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.
Bone
; 46(2): 534-42, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19786130
8.
Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Curr Med Res Opin
; 22(10): 1939-47, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17022853
9.
A factorial design to optimize cell-based drug discovery analysis.
J Chem Inf Comput Sci
; 42(5): 1221-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12377012
10.
Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
Diabetes Care
; 30(7): 1862-4, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17468348